DK2108366T3 - Idebenon til behandling af respiratorisk sygdom ved muskeldystrofi - Google Patents
Idebenon til behandling af respiratorisk sygdom ved muskeldystrofiInfo
- Publication number
- DK2108366T3 DK2108366T3 DK08007069.1T DK08007069T DK2108366T3 DK 2108366 T3 DK2108366 T3 DK 2108366T3 DK 08007069 T DK08007069 T DK 08007069T DK 2108366 T3 DK2108366 T3 DK 2108366T3
- Authority
- DK
- Denmark
- Prior art keywords
- idebenone
- muscular dystrophy
- treatment
- respiratory disease
- hydroxydecyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08007069A EP2108366B1 (en) | 2008-04-09 | 2008-04-09 | Idebenone for the treatment of respiratory illness in muscular dystrophy |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2108366T3 true DK2108366T3 (da) | 2012-01-30 |
Family
ID=39691216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08007069.1T DK2108366T3 (da) | 2008-04-09 | 2008-04-09 | Idebenon til behandling af respiratorisk sygdom ved muskeldystrofi |
Country Status (17)
Country | Link |
---|---|
US (1) | US20110092469A1 (da) |
EP (1) | EP2108366B1 (da) |
JP (1) | JP2011516513A (da) |
AT (1) | ATE529104T1 (da) |
AU (1) | AU2009235681B2 (da) |
CA (1) | CA2719440C (da) |
CY (1) | CY1112313T1 (da) |
DK (1) | DK2108366T3 (da) |
ES (1) | ES2370607T3 (da) |
HR (1) | HRP20110813T1 (da) |
MX (1) | MX2010011099A (da) |
NZ (1) | NZ588181A (da) |
PL (1) | PL2108366T3 (da) |
PT (1) | PT2108366E (da) |
SI (1) | SI2108366T1 (da) |
WO (1) | WO2009124693A1 (da) |
ZA (1) | ZA201006905B (da) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10806703B2 (en) * | 2012-01-20 | 2020-10-20 | Lts Lohmann Therapie-System Ag | Transmucosal administration system for a pharmaceutical drug |
EP2620141A1 (en) * | 2012-01-25 | 2013-07-31 | Santhera Pharmaceuticals (Schweiz) AG | Thin film drug delivery system for the transmucosal administration of a 1,4-benzoquinone derivative |
WO2014035356A1 (en) * | 2012-08-31 | 2014-03-06 | Mahmut Bilgic | Tablet formulations comprising a quinone derivative active agent |
CN103040779B (zh) * | 2013-01-01 | 2015-04-15 | 刘炜 | 用于神经系统疾病的口服固体药物组合物 |
CA2906812A1 (en) * | 2013-03-15 | 2014-09-18 | Sarepta Therapeutics, Inc. | Improved compositions for treating muscular dystrophy |
CN109364050B (zh) * | 2018-10-19 | 2021-02-02 | 大连医科大学 | 艾地苯醌在制备治疗肺动脉高压药物中的应用 |
WO2022258629A1 (en) | 2021-06-07 | 2022-12-15 | Katholieke Universiteit Leuven | Idebenone in the treatment of drug resistant epilepsy |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51128932A (en) | 1975-04-30 | 1976-11-10 | Takeda Chem Ind Ltd | Organic compounds |
JPH11116470A (ja) | 1997-08-12 | 1999-04-27 | Takeda Chem Ind Ltd | イデベノン含有経皮投与製剤 |
WO1999007355A1 (fr) | 1997-08-12 | 1999-02-18 | Takeda Chemical Industries, Ltd. | Preparation contenant de l'idebenone pour administration par voie percutanee |
CA2272971C (en) | 1998-10-29 | 2008-01-15 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Quinone derivatives for treating or preventing diseases associated with iron overload |
US7977388B2 (en) * | 2005-03-21 | 2011-07-12 | Santhera Pharmaceuticals (Schweiz) Ag | Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of muscular dystrophies |
EP1891946A1 (en) | 2006-08-14 | 2008-02-27 | Santhera Pharmaceuticals (Schweiz) AG | Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone |
-
2008
- 2008-04-09 EP EP08007069A patent/EP2108366B1/en active Active
- 2008-04-09 PT PT08007069T patent/PT2108366E/pt unknown
- 2008-04-09 PL PL08007069T patent/PL2108366T3/pl unknown
- 2008-04-09 AT AT08007069T patent/ATE529104T1/de active
- 2008-04-09 SI SI200830477T patent/SI2108366T1/sl unknown
- 2008-04-09 DK DK08007069.1T patent/DK2108366T3/da active
- 2008-04-09 ES ES08007069T patent/ES2370607T3/es active Active
-
2009
- 2009-04-03 CA CA2719440A patent/CA2719440C/en not_active Expired - Fee Related
- 2009-04-03 AU AU2009235681A patent/AU2009235681B2/en not_active Ceased
- 2009-04-03 US US12/934,089 patent/US20110092469A1/en not_active Abandoned
- 2009-04-03 NZ NZ588181A patent/NZ588181A/en not_active IP Right Cessation
- 2009-04-03 MX MX2010011099A patent/MX2010011099A/es active IP Right Grant
- 2009-04-03 WO PCT/EP2009/002478 patent/WO2009124693A1/en active Application Filing
- 2009-04-03 JP JP2011503366A patent/JP2011516513A/ja active Pending
-
2010
- 2010-09-28 ZA ZA2010/06905A patent/ZA201006905B/en unknown
-
2011
- 2011-11-02 HR HR20110813T patent/HRP20110813T1/hr unknown
-
2012
- 2012-01-18 CY CY20121100068T patent/CY1112313T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PL2108366T3 (pl) | 2012-03-30 |
CA2719440C (en) | 2013-07-16 |
HRP20110813T1 (hr) | 2011-11-30 |
JP2011516513A (ja) | 2011-05-26 |
US20110092469A1 (en) | 2011-04-21 |
ZA201006905B (en) | 2011-06-29 |
AU2009235681B2 (en) | 2012-04-05 |
SI2108366T1 (sl) | 2012-01-31 |
MX2010011099A (es) | 2010-11-01 |
CY1112313T1 (el) | 2015-12-09 |
EP2108366B1 (en) | 2011-10-19 |
PT2108366E (pt) | 2011-11-10 |
WO2009124693A1 (en) | 2009-10-15 |
ES2370607T3 (es) | 2011-12-20 |
CA2719440A1 (en) | 2009-10-15 |
ATE529104T1 (de) | 2011-11-15 |
NZ588181A (en) | 2011-11-25 |
EP2108366A1 (en) | 2009-10-14 |
AU2009235681A1 (en) | 2009-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2108366T3 (da) | Idebenon til behandling af respiratorisk sygdom ved muskeldystrofi | |
LTC2444424I2 (lt) | Pagerintos TM nanodalelės, skirtos agregacijos sąlygotų sutrikimų gydymui | |
CY1116828T1 (el) | Πεπτιδια για απευαισθητοποιηση απο αλλεργιογονα | |
CY1114872T1 (el) | Συνθεσεις και μεθοδοι χρησης αντισωματων εναντι της σκληροστεϊνης | |
EA201101477A1 (ru) | Органические соединения и их применение | |
BR112012014715A2 (pt) | "processo de tratamento cosmético da pele, e, conjunto cosmético" | |
IL198922A0 (en) | Chemical compounds and uses | |
WO2009108856A3 (en) | Microrna signatures associated with human chronic lymphocytic leukemia (ccl) and uses thereof | |
BRPI0921117A2 (pt) | processo de montagem de uma peça inserida, dispositivo de fixação intermediária, vidraça e utilização do dispositivo de fixação intermediária. | |
BRPI0717822A2 (pt) | Composto, processo de fabricação de composto da fórmula i, composição farmacêutica, método de tratamento e/ou profilaxia de doenças que são associadas à modulação de receptores de cb2 e uso de composto. | |
BRPI0717753A2 (pt) | Método de tratamento ou redução do risco de uma doença causada por protozoários, e, composição. | |
BRPI0919918A2 (pt) | Composto de vanilina e de etilvanilina, processo de preparação do mesmo, composição, e, aplicação do composto. | |
WO2009068803A3 (fr) | Utilisation de solutions d'huile de menthe ou de l-carvone pour le traitement fongicide et/ou antigerminatif des bulbes et/ou tubercules | |
DK3689346T3 (da) | 3,6-disubstitueret xanthyliumsalte til behandling af tauopati | |
ATE496913T1 (de) | Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen | |
UA102414C2 (ru) | Циклоундекадепсипептидные соединения для лечения инфекций, вызванных вирусом гепатита с | |
BRPI1011535A2 (pt) | tratamento de distúrbios resistentes à insulina. | |
EA201170567A1 (ru) | Смесь силанов | |
NO20082203L (no) | Fremgangsmater for a behandle sentralnervesystemforstyrrelser med en lavdosekombinasjon av escitalopram og bupropion | |
WO2008155390A3 (en) | Use of inhibitors of sirtuins and/or ampk for the preparation of a medicament for the treatment of polyalanine diseases. | |
BRPI0821234A2 (pt) | Processo de preparação de pirocatecol purificado, e pirocatecol. | |
DK2323686T3 (da) | Adiponectin til behandling af lungesygdom | |
WO2009098355A8 (en) | Novel use of probiotics | |
ATE527996T1 (de) | Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium)propionat-orotat | |
BR112014029183A2 (pt) | método para a fabricação de um documento de valor |